Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04753957 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Progesterone in Pregnancy-2
A Phase 1 study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT04753957 is a Phase 1 study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 3 participants.
The verdict
NCT04753957, a Phase 1 study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the local pharmacokinetics of progesterone in pregnancy through evaluation of progesterone levels in maternal serum, endometrium, and cordblood in pregnant patients undergoing scheduled cesarean delivery.
Interventions
- DRUG micronized Progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-01-07 |
| Est. Completion | 2022-02-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04753957
The ClinicalTrials.gov registry entry for NCT04753957 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which micronized Progesterone is the first listed.
NCT04753957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04753957 about?
NCT04753957 is a clinical study titled "Pharmacokinetics of Progesterone in Pregnancy-2". The objective of this study is to evaluate the local pharmacokinetics of progesterone in pregnancy through evaluation of progesterone levels in maternal serum, endometrium, and cordblood in pregnant patients undergoing scheduled cesarean delivery.
What is the current status of trial NCT04753957?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2022-01-07. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT04753957?
The interventions under investigation include: micronized Progesterone (DRUG).
Who is sponsoring clinical trial NCT04753957?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.